2020
DOI: 10.1111/odi.13526
|View full text |Cite
|
Sign up to set email alerts
|

Is povidone iodine mouthwash effective against SARS‐CoV‐2? First in vivo tests

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
104
1
5

Year Published

2020
2020
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 98 publications
(114 citation statements)
references
References 13 publications
4
104
1
5
Order By: Relevance
“…37 On the basis of an in vitro study demonstrating inactivation of SARS-CoV-2 and a small case series showing a significant reduction in COVID-19 viral loads in 2 of 4 patients using a povidone-iodine mouthwash, we have started to use 0.5% povidone-iodine irrigation during our mastoidectomy procedures. 38,39 Samplers that are commonly used for bioaerosol sampling are not designed to collect nanosized viral aerosols. 14…”
Section: Discussionmentioning
confidence: 99%
“…37 On the basis of an in vitro study demonstrating inactivation of SARS-CoV-2 and a small case series showing a significant reduction in COVID-19 viral loads in 2 of 4 patients using a povidone-iodine mouthwash, we have started to use 0.5% povidone-iodine irrigation during our mastoidectomy procedures. 38,39 Samplers that are commonly used for bioaerosol sampling are not designed to collect nanosized viral aerosols. 14…”
Section: Discussionmentioning
confidence: 99%
“…The first case report on efficacy of mouth-rinses in reducing the SARS-CoV-2 viral load in the saliva was reported in Korea [ 10 ]. Subsequently, Martínez Lamas et al, 2020 in a case-series of four patients suggested that PI mouth-rinse could reduce the saliva viral load of SARS-CoV-2 in patients with higher viral loads [ 11 ]. A recent in vitro study has shown the efficacy virucidal activity of certain commercially available mouth-rinses against SARS-CoV-2 [ 12 ].…”
Section: Introductionmentioning
confidence: 99%
“…A partir da análise do impacto que um enxaguante bucal com povidine causou na carga viral salivar de SARS-CoV-2 em 4 pacientes com COVID-19, Martínez Lamas et al 50 identificaram que, até o momento, a eficácia do povidine contra SARS-CoV-2 não está confirmada. Contudo, mesmo diante das limitações do estudo, esses resultados preliminares in vivo sugeriram que um enxágue com povidine poderia reduzir a concentração da carga viral salivar de SARS-CoV-2 em pacientes com cargas virais mais altas.…”
Section: Discussionunclassified